Cargando…

Third-generation cephalosporin resistance of community-onset Escherichia coli and Klebsiella pneumoniae bacteremia in a secondary hospital

BACKGROUND/AIMS: To enable appropriate antimicrobial treatment for community-onset infections in emergency departments (EDs), data are needed on the resistance profiles of Escherichia coli and Klebsiella pneumoniae, which are the main pathogens of community-onset bacteremia. METHODS: Records were re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Shinwon, Han, Seung Woo, Kim, Kun Woo, Song, Do Young, Kwon, Ki Tae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932395/ https://www.ncbi.nlm.nih.gov/pubmed/24574833 http://dx.doi.org/10.3904/kjim.2014.29.1.49

Ejemplares similares

Effect of rapid cefpodoxime disk screening for early detection of third-generation cephalosporin resistance in Escherichia coli and Klebsiella pneumoniae bacteremia
por: Sakai, Mikiyasu, et al.
Publicado: (2023)

Comparison of antimicrobial resistances and clinical features in community-onset Escherichia coli and Klebsiella pneumoniae bacteremia
por: Sung, Hwa Seok, et al.
Publicado: (2021)

1605. Differences in Clinical Characteristics of Third Generation Cephalosporin Resistance and Treatment Outcomes in Escherichia coli and Klebsiella pneumoniae Bacteremia in Patients with Liver Cirrhosis
por: Ham, Sin Young, et al.
Publicado: (2020)

Prevalence of and risk factor for community-onset third-generation cephalosporin-resistant Escherichia coli bacteremia at a medical center in Taiwan
por: Lin, Wu-Pu, et al.
Publicado: (2019)

Activity of temocillin against third-generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae bloodstream isolates from a clinical trial
por: Stewart, Adam G, et al.
Publicado: (2021)

Comparative in vitro activity of piperacillin-tazobactam and temocillin against third-generation cephalosporin-resistant, carbapenem-susceptible Escherichia coli and Klebsiella pneumoniae
por: Kresken, Michael, et al.
Publicado: (2021)

The Clinical Evaluation of Third-generation Cephalosporins As Definitive Therapy for Enterobacter spp. and Klebsiella aerogenes Bacteremia
por: Kobayashi, Kazuhiro, et al.
Publicado: (2022)

Clinical and Economic Impact of Third-Generation Cephalosporin-Resistant Infection or Colonization Caused by Escherichia coli and Klebsiella pneumoniae: A Multicenter Study in China
por: Zhen, Xuemei, et al.
Publicado: (2020)

Determining the in vitro susceptibility of tebipenem, an oral carbapenem, against third-generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolated from bloodstream infections
por: Ranasinghe, Ama, et al.
Publicado: (2022)

Investigating Possible Interspecies Communication of Plasmids Associated with Transfer of Third-Generation Cephalosporin, Quinolone, and Colistin Resistance Between Simultaneously Isolated Escherichia Coli and Klebsiella Pneumoniae
por: Quan, Jingjing, et al.
Publicado: (2023)

Risk Factors for Mortality in Patients with Klebsiella pneumoniae Carbapenemase-producing K. pneumoniae and Escherichia coli bacteremia
por: Seo, Hyeonji, et al.
Publicado: (2021)

Propensity score matched analysis comparing the clinical outcome of Klebsiella pneumoniae and Escherichia coli causing community-onset monomicrobial bacteremia
por: Kuo, Tsung-Hang, et al.
Publicado: (2017)

Clinical Usefulness of the 2010 Clinical and Laboratory Standards Institute Revised Breakpoints for Cephalosporin Use in the Treatment of Bacteremia Caused by Escherichia coli or Klebsiella spp.
por: Ku, Nam Su, et al.
Publicado: (2015)

Trends in Expanded-Spectrum Cephalosporin-Resistant Escherichia coli and Klebsiella pneumoniae among Dutch Clinical Isolates, from 2008 to 2012
por: van der Steen, Matthijs, et al.
Publicado: (2015)

Epidemiology of paediatric gastrointestinal colonisation by extended spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates in north-west Cambodia
por: van Aartsen, J. J., et al.
Publicado: (2019)

The Emergence of Klebsiella pneumoniae with Reduced Susceptibility against Third Generation Cephalosporins and Carbapenems in Lagos Hospitals, Nigeria
por: Akinyemi, Kabiru O., et al.
Publicado: (2021)

Third generation cephalosporin-resistant Klebsiella pneumoniae thriving in patients and in wastewater: what do they have in common?
por: Rocha, Jaqueline, et al.
Publicado: (2022)

Surveillance and Genomic Analysis of Third-Generation Cephalosporin-Resistant and Carbapenem-Resistant Klebsiella pneumoniae Complex in Germany
por: Xanthopoulou, Kyriaki, et al.
Publicado: (2022)

Impact of Empiric Antimicrobial Therapy on Outcomes in Patients with Escherichia coli and Klebsiella pneumoniae Bacteremia: A Cohort Study
por: Thom, Kerri A, et al.
Publicado: (2008)

No association between resistance mutations, empiric antibiotic, and mortality in ceftriaxone-resistant Escherichia coli and Klebsiella pneumoniae bacteremia
por: Heng, Shi Thong, et al.
Publicado: (2018)

A Rare Case of Third Generation Cephalosporin-Resistant Klebsiella Meningitis
por: Zeeshan, Adiba, et al.
Publicado: (2022)

Genomic Analysis of Third Generation Cephalosporin Resistant Escherichia coli from Dairy Cow Manure
por: Rehman, Muhammad Attiq, et al.
Publicado: (2017)

MCR1 and KPC2 Co-producing Klebsiella pneumoniae Bacteremia: First Case in Korea
por: Park, Ji Young, et al.
Publicado: (2019)

Association of Veterinary Third-Generation Cephalosporin Use with the Risk of Emergence of Extended-Spectrum-Cephalosporin Resistance in Escherichia coli from Dairy Cattle in Japan
por: Sato, Toyotaka, et al.
Publicado: (2014)

Genetic relatedness of third-generation cephalosporin-resistant Escherichia coli among livestock, farmers, and patients in Japan
por: Nakano, Ryuichi, et al.
Publicado: (2023)

Definitive Cefazolin Therapy for Stabilized Adults with Community-Onset Escherichia coli, Klebsiella Species, and Proteus mirabilis Bacteremia: MIC Matters
por: Hsieh, Chih-Chia, et al.
Publicado: (2020)

Hemophagocytic Lymphohistiocytosis Secondary to Obstructive Uropathy and Escherichia coli Bacteremia
por: Hofstrand, Reese, et al.
Publicado: (2023)

Clinical outcome of empiric antimicrobial therapy of bacteremia due to extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae
por: Chaubey, Vikas P, et al.
Publicado: (2010)

Genetic characterization of third- or fourth-generation cephalosporin-resistant avian pathogenic Escherichia coli isolated from broilers
por: Kang, Hyo Jung, et al.
Publicado: (2022)

Limitations in predicting reduced susceptibility to third generation cephalosporins in Escherichia coli based on whole genome sequence data
por: Heydecke, Anna, et al.
Publicado: (2023)

Long-term outbreak of Klebsiella pneumoniae & third generation cephalosporin use in a neonatal intensive care unit in north India
por: Banerjee, Tuhina, et al.
Publicado: (2016)

Minimal impact of selective susceptibility reporting on the use of piperacillin-tazobactam for Escherichia coli and Klebsiella bacteremia
por: Zahlanie, Yorgo, et al.
Publicado: (2021)

Klebsiella pneumoniae Bacteremia and Capsular Serotypes, Taiwan
por: Liao, Chun-Hsing, et al.
Publicado: (2011)

Recurrent Klebsiella pneumoniae Bacteremia Due to Endotipsitis
por: Everett, Scott, et al.
Publicado: (2023)

Impact of Inappropriate Empirical Antibiotic on Outcomes in Community-acquired Third Generation Cephalosporin Resistant Enterobacterales Bacteremia
por: Nasomsong, Worapong, et al.
Publicado: (2022)

1508. Carbapenem vs. Non-carbapenem as Empiric Regimens for Bacteremia Caused by ESBL Producing Escherichia coli and Klebsiella pneumoniae in Children: Preliminary Study
por: Park, Saera, et al.
Publicado: (2019)

427. Trends in Hospital-onset Escherichia coli Infections Resistant to Fluoroquinolones and Extended-spectrum Cephalosporins, 2012-2020
por: Hood, Nicole, et al.
Publicado: (2022)

1061. Decreased Utilization of Piperacillin–Tazobactam for Escherichia coli and Klebsiella Bacteremia due to Selective Susceptibility Reporting
por: Zahlanie, Yorgo, et al.
Publicado: (2019)

Comparison of Escherichia coli and Klebsiella pneumoniae Acute Pyelonephritis in Korean Patients
por: Hyun, Miri, et al.
Publicado: (2019)

ESBL‐production in Escherichia coli and Klebsiella pneumoniae isolates from Nigeria
por: Hertz, Frederik B., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2mpmq3u6s1s6f3picgt33gu39r